{"gene":"POLR1A","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":1988,"finding":"The yeast RPA190 gene encodes the largest subunit (A190, 186 kDa) of RNA polymerase I; the gene is unique in the haploid genome and essential for cell viability. Sequence analysis revealed conserved homology regions (I–VI) shared with E. coli beta' and the largest subunits of RNA Pol II and Pol III, including a conserved N-terminal zinc-binding (DNA-binding) motif. A190 lacks the heptapeptide CTD repeat present in the Pol II large subunit and contains two unique hydrophilic insertion domains.","method":"Gene isolation, Southern hybridization, gene disruption, nuclease S1 mapping, DNA sequencing, dot-matrix sequence comparison","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — gene disruption (essential viability) + full sequence characterization; foundational paper, 101 citations","pmids":["2830265"],"is_preprint":false},{"year":1988,"finding":"Temperature-sensitive mutations in yeast RPA190 (the POLR1A ortholog) cause defective rRNA accumulation and reduced RNA polymerase I activity in vitro at the non-permissive temperature, while 5S RNA synthesis is relatively unaffected. Fine-structure mapping showed that two ts mutations (rpa190-1 and rpa190-5) cluster in the conserved zinc-binding region I; rpa190-3 maps to a previously unidentified highly conserved segment between regions III and IV and appears to reduce enzyme levels; rpa190-2 creates a UGA nonsense codon.","method":"In vitro hydroxylamine mutagenesis, plasmid shuffle, pulse-labeling of RNA, partial purification of RNA Pol I and in vitro assay, fine-structure mapping, DNA sequencing","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzyme activity assay combined with mutagenesis and in vivo RNA labeling","pmids":["3054507"],"is_preprint":false},{"year":1990,"finding":"Conditional depletion of RPA190 (yeast POLR1A ortholog) via galactose-promoter control causes preferential loss of rRNA synthesis; ribosomal protein accumulation subsequently decreases to match the reduced rRNA synthesis rate, largely through post-translational degradation of excess r-proteins rather than transcriptional repression of r-protein mRNAs. An exception is L32 pre-mRNA splicing, which is feedback-inhibited when rRNA decreases.","method":"Galactose-promoter conditional expression system, pulse-chase labeling, polysome analysis, Northern blotting","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with defined molecular phenotype, multiple orthogonal readouts","pmids":["2183018"],"is_preprint":false},{"year":2001,"finding":"hRRN3 defines a transcriptionally competent subpopulation of RNA Polymerase I (Pol I beta) and is required for Pol I recruitment to rDNA promoters. hRRN3 physically interacts with the SL1 subunits TAF(I)110 and TAF(I)63; blocking this interaction prevents Pol I recruitment to the promoter. hRRN3 can also be found in Pol I holoenzyme complexes capable of autonomous transcription.","method":"Affinity purification, co-immunoprecipitation, in vitro transcription assay, chromatin immunoprecipitation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — reconstituted transcription assay + reciprocal co-IP + ChIP; 155 citations","pmids":["11250903"],"is_preprint":false},{"year":2002,"finding":"In living cells, mammalian RNA Polymerase I components are recruited to ribosomal genes as distinct subunits and assembly occurs via metastable intermediates rather than as a preformed holoenzyme. In vivo elongation time of the polymerase was determined by computational modeling of FRAP data; incorporation of components into the assembling polymerase is inefficient.","method":"In vivo fluorescence microscopy (FRAP), computational modeling of imaging data, stable cell lines expressing GFP-tagged Pol I subunits","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 — quantitative live-cell FRAP with computational kinetic modeling; 345 citations","pmids":["12446911"],"is_preprint":false},{"year":2006,"finding":"SIRT7 is a nucleolar protein that associates with RNA Polymerase I at active rRNA genes. Overexpression of SIRT7 increases Pol I-mediated transcription; knockdown of SIRT7 or inhibition of its catalytic activity reduces Pol I association with rDNA and decreases Pol I transcription. SIRT7 depletion stops cell proliferation and triggers apoptosis.","method":"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), RNAi knockdown, overexpression, cell proliferation and apoptosis assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP + ChIP + functional KD/OE; 478 citations","pmids":["16618798"],"is_preprint":false},{"year":2012,"finding":"Functional proteomics of SIRT7 confirmed its interaction with RNA Pol I and upstream binding factor (UBF) and revealed association with chromatin remodeling complexes (B-WICH complex members: Mybbp1a, WSTF, SNF2h). SIRT7 knockdown reduces RNA Pol I protein levels (but not mRNA), implicating SIRT7 in stabilization of the Pol I machinery.","method":"EGFP-tagged SIRT7 affinity purification, mass spectrometry, SRM-like quantitative proteomics with SILAC, confocal microscopy, reciprocal immunoaffinity precipitation, siRNA knockdown","journal":"Molecular & cellular proteomics","confidence":"High","confidence_rationale":"Tier 1–2 — comprehensive proteomic interaction map with multiple validation methods; 145 citations","pmids":["22586326"],"is_preprint":false},{"year":2013,"finding":"SIRT7 deacetylates PAF53 (a subunit of RNA Polymerase I) at lysine 373; acetylation of PAF53 by CBP reduces Pol I–rDNA occupancy and transcription, while SIRT7-mediated deacetylation promotes it. Under stress, SIRT7 is released from nucleoli in an RNA-dependent manner, leading to PAF53 hyperacetylation and reduced Pol I transcription. SIRT7 nucleolar retention requires binding to nascent pre-rRNA.","method":"In vitro deacetylation assay, acetylation-site mutagenesis, ChIP, RNA immunoprecipitation, fluorescence microscopy, stress-induced SIRT7 relocalization assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay + mutagenesis + ChIP + mechanistic RNA-binding studies; 167 citations","pmids":["24207024"],"is_preprint":false},{"year":2013,"finding":"RNA Polymerase I-specific transcription factors (including SL1/TIF-IB, UBF, RRN3/TIF-IA) guide Pol I to the rDNA promoter and contribute to multiple rounds of initiation, promoter escape, elongation, and termination. Accessory factors integrate transcriptional activity with metabolic demands, and rDNA chromatin organization/epigenetic state impinges on Pol I output. Deregulated Pol I transcription is a feature of cancer.","method":"Review integrating biochemical reconstitution, ChIP, and mutagenesis studies from multiple labs","journal":"Sub-cellular biochemistry","confidence":"High","confidence_rationale":"Tier 1–2 — review synthesizing decades of reconstitution and mechanistic studies; 142 citations","pmids":["23150253"],"is_preprint":false},{"year":2015,"finding":"Heterozygous mutations in POLR1A (encoding the largest subunit of RNA Polymerase I, RPA194) cause acrofacial dysostosis, Cincinnati type. polr1a mutant zebrafish exhibit cranioskeletal anomalies; polr1a loss of function leads to perturbed ribosome biogenesis, p53-dependent cell death, and deficiency of neural-crest-derived skeletal precursor cells, resulting in craniofacial anomalies.","method":"Human exome sequencing, zebrafish polr1a morpholino/mutant model, ribosome biogenesis assays, p53 pathway analysis, skeletal staining","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — in vivo zebrafish model with defined molecular phenotype (ribosome biogenesis, p53 apoptosis) + human genetics","pmids":["25913037"],"is_preprint":false},{"year":2017,"finding":"A homozygous missense variant in POLR1A (c.2801C>T, p.Ser934Leu), encoding RPA194 (the largest subunit of RNA Pol I), causes complex leukodystrophy with neurodegeneration in humans. Skin fibroblasts from affected individuals showed decreased nucleolar RPA194 protein, linking POLR1A dysfunction to disrupted nucleolar function and leukodystrophy.","method":"Linkage analysis, exome sequencing, immunofluorescence of RPA194 in patient fibroblasts, segregation analysis","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — human genetics + functional validation in patient cells (single lab, limited mechanistic depth)","pmids":["28051070"],"is_preprint":false},{"year":2023,"finding":"Heterozygous pathogenic POLR1A variants cause a phenotypic spectrum including craniofacial anomalies, neurodevelopmental abnormalities, and structural cardiac defects. In vitro studies showed that individual variants have variable effects on ribosomal RNA synthesis and nucleolar morphology. Conditional mutagenesis in mice demonstrated that loss of Polr1a in neural crest cells, second heart field, or forebrain precursors causes cell-autonomous apoptosis and embryonic malformations in the corresponding tissues.","method":"Human cohort sequencing, in vitro rRNA synthesis assays, nucleolar morphology analysis, CRISPR-Cas9 knock-in mice, conditional (Cre-lox) mutagenesis in specific developmental lineages, embryonic phenotyping","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1–2 — allelic series in vitro + multiple conditional mouse KO lines with defined cell-autonomous apoptosis phenotypes","pmids":["37075751"],"is_preprint":false},{"year":2023,"finding":"A homozygous POLR1A missense variant (p.Thr642Asn) causes hypomyelinating leukodystrophy with cerebellar atrophy. In vitro experiments in patient fibroblasts demonstrated that mutant POLR1A leads to aberrant rRNA processing and degradation, abnormal nucleolar homeostasis, abnormal protein homeostasis, and endoplasmic reticulum stress responses.","method":"Exome sequencing, patient fibroblast culture, rRNA processing assays, nucleolar morphology, proteomics, ER stress marker analysis","journal":"Brain","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal in vitro mechanistic assays in patient-derived cells","pmids":["36917474"],"is_preprint":false},{"year":2025,"finding":"POLR1A (the catalytic subunit of RNA Polymerase I) controls TFAM expression via the transcription factor ATF4, and this POLR1A–ATF4–TFAM axis inhibits mitophagy and limits mitophagy-dependent labile Fe2+ release, thereby preventing Fe2+-driven lipid peroxidation and ferroptosis. Disruption of POLR1A or TFAM leads to Fe2+ accumulation and increased sensitivity to ferroptosis inducers. CX-5461 (a Pol I inhibitor) synergizes with GPX4 blockade to induce ferroptotic cell death in vitro and in vivo.","method":"POLR1A knockdown/inhibition (CX-5461), TFAM expression analysis, mitophagy assays, labile iron pool measurements, lipid peroxidation assays, GPX4 combination experiments, in vivo xenograft models","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 — functional KD with defined mechanistic pathway (POLR1A→ATF4→TFAM→mitophagy→Fe2+→ferroptosis), single lab","pmids":["40669210"],"is_preprint":false}],"current_model":"POLR1A encodes the largest catalytic subunit (RPA194/A190) of RNA Polymerase I, which is essential for rDNA transcription and ribosome biogenesis; it is recruited to rDNA promoters via RRN3–SL1 interactions, its activity is regulated by SIRT7-mediated deacetylation of the associated subunit PAF53, and loss-of-function variants cause p53-dependent apoptosis of neural crest cells (producing craniofacial dysostosis), leukodystrophy via aberrant rRNA processing and ER stress, while a newly identified nucleolar-mitochondrial axis links POLR1A to ATF4-TFAM-dependent mitophagy and ferroptosis resistance."},"narrative":{"teleology":[{"year":1988,"claim":"Identification of the largest Pol I subunit gene (RPA190) as a single-copy essential gene with conserved polymerase motifs established POLR1A as the catalytic core of rDNA transcription.","evidence":"Yeast gene disruption, sequencing, and dot-matrix comparison revealing conserved regions I–VI shared with Pol II/III largest subunits and E. coli β'","pmids":["2830265","3054507"],"confidence":"High","gaps":["No three-dimensional structure of the A190 subunit or Pol I holoenzyme at this time","Mechanism of promoter recognition and subunit assembly unknown"]},{"year":1990,"claim":"Conditional depletion of RPA190 demonstrated that rRNA synthesis is rate-limiting for ribosome production and that excess ribosomal proteins are degraded post-translationally, establishing the cellular consequences of Pol I loss.","evidence":"Galactose-promoter conditional expression of RPA190 in yeast with pulse-chase labeling and polysome analysis","pmids":["2183018"],"confidence":"High","gaps":["Post-translational degradation pathway for excess ribosomal proteins not identified","Mammalian equivalence of this regulatory coupling not yet tested"]},{"year":2001,"claim":"Discovery that hRRN3 defines a transcription-competent Pol I subpopulation and bridges Pol I to the SL1 promoter-recognition complex resolved how Pol I is recruited to rDNA promoters.","evidence":"Affinity purification, reciprocal co-IP, in vitro transcription reconstitution, and ChIP in human cells","pmids":["11250903"],"confidence":"High","gaps":["Structural basis of the RRN3–Pol I and RRN3–SL1 interfaces unknown","Regulation of RRN3 availability as a rate-limiting step not fully dissected"]},{"year":2002,"claim":"Live-cell FRAP showed that Pol I assembles at rDNA promoters from individual subunits through metastable intermediates rather than as a preformed holoenzyme, redefining the assembly paradigm.","evidence":"GFP-tagged Pol I subunits in mammalian cell lines, quantitative FRAP with kinetic modeling","pmids":["12446911"],"confidence":"High","gaps":["Identity and order of metastable assembly intermediates not resolved biochemically","Stoichiometry of on-chromatin versus off-chromatin pools unclear"]},{"year":2006,"claim":"SIRT7 was identified as a nucleolar activator of Pol I transcription that associates with active rRNA genes, linking NAD+-dependent signaling to rDNA output.","evidence":"Co-IP, ChIP at rDNA, SIRT7 knockdown and overexpression with Pol I transcription readouts","pmids":["16618798"],"confidence":"High","gaps":["Direct enzymatic substrate of SIRT7 on the Pol I machinery not yet identified","Whether SIRT7 acts directly on POLR1A or on an accessory factor unknown"]},{"year":2013,"claim":"SIRT7 was shown to deacetylate PAF53 at K373, establishing a specific post-translational switch that tunes Pol I–rDNA occupancy; stress-induced SIRT7 release causes PAF53 hyperacetylation and Pol I shutdown.","evidence":"In vitro deacetylation assay, acetylation-site mutagenesis, ChIP, RNA immunoprecipitation, stress-relocalization assays","pmids":["24207024","22586326"],"confidence":"High","gaps":["Whether SIRT7 also deacetylates POLR1A/RPA194 itself not tested","Upstream kinase/phosphatase inputs that trigger SIRT7 nucleolar release not defined"]},{"year":2015,"claim":"Human heterozygous POLR1A mutations were shown to cause acrofacial dysostosis (Cincinnati type), with zebrafish modeling demonstrating that Polr1a haploinsufficiency impairs ribosome biogenesis and induces p53-dependent apoptosis selectively in neural crest cells.","evidence":"Human exome sequencing, zebrafish morpholino/mutant, ribosome biogenesis assays, p53 pathway analysis, skeletal staining","pmids":["25913037"],"confidence":"High","gaps":["Why neural crest cells are selectively sensitive to Pol I haploinsufficiency remains unclear","Contribution of individual ribosomal RNA species versus global ribosome shortage not dissected"]},{"year":2023,"claim":"An allelic series of POLR1A variants was linked to a broad phenotypic spectrum (craniofacial, cardiac, neurodevelopmental) and conditional mouse knockouts demonstrated cell-autonomous apoptosis in neural crest, second heart field, and forebrain lineages, expanding the disease paradigm beyond craniofacial dysostosis. Separately, biallelic variants were shown to cause leukodystrophy via aberrant rRNA processing and ER stress.","evidence":"Human cohort sequencing, CRISPR knock-in and Cre-lox conditional mice, patient fibroblast rRNA processing and ER stress assays","pmids":["37075751","36917474","28051070"],"confidence":"High","gaps":["How specific missense variants differentially affect Pol I catalytic activity versus assembly remains unclear","Whether ER stress in leukodystrophy is a direct consequence of unfolded protein accumulation from reduced ribosome output not proven","No rescue experiments with wild-type POLR1A in mouse or patient cells reported"]},{"year":2025,"claim":"A nucleolar–mitochondrial signaling axis was uncovered in which POLR1A controls TFAM expression through ATF4, restraining mitophagy-dependent labile iron release and conferring ferroptosis resistance — revealing a non-canonical function linking Pol I activity to mitochondrial quality control.","evidence":"POLR1A knockdown/CX-5461 inhibition, TFAM expression analysis, mitophagy and labile iron assays, lipid peroxidation readouts, in vivo xenograft synergy with GPX4 inhibition","pmids":["40669210"],"confidence":"Medium","gaps":["Single-lab finding; independent replication needed","Whether ATF4 induction is a direct transcriptional consequence of reduced rRNA or a secondary stress response is unresolved","Relevance of this axis to POLR1A-associated human diseases not tested"]},{"year":null,"claim":"Key open questions include the structural basis for variant-specific catalytic defects, the tissue-selective vulnerability mechanisms in ribosomopathy phenotypes, and whether the POLR1A–ATF4–TFAM ferroptosis axis operates in vivo under physiological Pol I stress.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of human Pol I with disease-associated POLR1A variants","Tissue-specific ribosome biogenesis thresholds not quantified","In vivo significance of ferroptosis regulation by POLR1A unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,1,2,8]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[5,6,7,10,12]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,5]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,2,3,7,8]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[2,9,12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,10,11,12]}],"complexes":["RNA Polymerase I"],"partners":["RRN3","SIRT7","PAF53","UBF","TAFI110","TAFI63","ATF4","TFAM"],"other_free_text":[]},"mechanistic_narrative":"POLR1A encodes the largest catalytic subunit (RPA194/A190) of RNA Polymerase I, the enzyme dedicated to ribosomal DNA transcription and ribosome biogenesis. The subunit harbors conserved zinc-binding and catalytic regions shared with other multi-subunit RNA polymerases, is essential for cell viability, and is recruited to rDNA promoters through RRN3–SL1 interactions; its transcriptional output is positively regulated by SIRT7-mediated deacetylation of the associated subunit PAF53 [PMID:2830265, PMID:11250903, PMID:24207024]. Heterozygous loss-of-function variants in POLR1A cause acrofacial dysostosis (Cincinnati type) with p53-dependent neural crest cell apoptosis, while biallelic missense variants cause hypomyelinating leukodystrophy linked to aberrant rRNA processing and endoplasmic reticulum stress [PMID:25913037, PMID:36917474, PMID:37075751]. A nucleolar–mitochondrial signaling axis has been identified in which POLR1A controls TFAM expression via ATF4, suppressing mitophagy-dependent labile iron release and ferroptosis [PMID:40669210]."},"prefetch_data":{"uniprot":{"accession":"O95602","full_name":"DNA-directed RNA polymerase I subunit RPA1","aliases":["A190","DNA-directed RNA polymerase I largest subunit","DNA-directed RNA polymerase I subunit A","RNA polymerase I 194 kDa subunit","RPA194"],"length_aa":1720,"mass_kda":194.8,"function":"Catalytic core component of RNA polymerase I (Pol I), a DNA-dependent RNA polymerase which synthesizes ribosomal RNA precursors using the four ribonucleoside triphosphates as substrates. Transcribes 47S pre-rRNAs from multicopy rRNA gene clusters, giving rise to 5.8S, 18S and 28S ribosomal RNAs (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492). Pol I-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol I pre-initiation complex (PIC) is recruited by the selectivity factor 1 (SL1/TIF-IB) complex bound to the core promoter that precedes an rDNA repeat unit. The PIC assembly bends the promoter favoring the formation of the transcription bubble and promoter escape. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Highly processive, assembles in structures referred to as 'Miller trees' where many elongating Pol I complexes queue and transcribe the same rDNA coding regions. At terminator sequences downstream of the rDNA gene, PTRF interacts with Pol I and halts Pol I transcription leading to the release of the RNA transcript and polymerase from the DNA (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492). Forms Pol I active center together with the second largest subunit POLR1B/RPA2. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR1A/RPA1 contributing a Mg(2+)-coordinating DxDGD motif, and POLR1B/RPA2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and the template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate. Has proofreading activity: Pauses and backtracks to allow the cleavage of a missincorporated nucleotide via POLR1H/RPA12. High Pol I processivity is associated with decreased transcription fidelity (By similarity) (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492)","subcellular_location":"Nucleus, nucleolus; Chromosome","url":"https://www.uniprot.org/uniprotkb/O95602/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POLR1A","classification":"Common Essential","n_dependent_lines":1203,"n_total_lines":1208,"dependency_fraction":0.9958609271523179},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000068654","cell_line_id":"CID000840","localizations":[{"compartment":"nucleolus_fc_dfc","grade":3}],"interactors":[{"gene":"POLR1B","stoichiometry":10.0},{"gene":"POLR2H","stoichiometry":10.0},{"gene":"POLR2K","stoichiometry":10.0},{"gene":"POLR1C","stoichiometry":4.0},{"gene":"POLR2E","stoichiometry":4.0},{"gene":"POLR2F","stoichiometry":4.0},{"gene":"CAPZB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000840","total_profiled":1310},"omim":[{"mim_id":"620675","title":"LEUKODYSTROPHY, HYPOMYELINATING, 27; HLD27","url":"https://www.omim.org/entry/620675"},{"mim_id":"620341","title":"WD REPEAT-CONTAINING PROTEIN 75; WDR75","url":"https://www.omim.org/entry/620341"},{"mim_id":"619729","title":"ACTIN-RELATED PROTEIN 6; ACTR6","url":"https://www.omim.org/entry/619729"},{"mim_id":"616462","title":"ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN","url":"https://www.omim.org/entry/616462"},{"mim_id":"616404","title":"POLYMERASE I, RNA, SUBUNIT A; POLR1A","url":"https://www.omim.org/entry/616404"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoli fibrillar center","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLR1A"},"hgnc":{"alias_symbol":["DKFZP586M0122","FLJ21915","RPO1-4","RPA1","RPA190"],"prev_symbol":[]},"alphafold":{"accession":"O95602","domains":[{"cath_id":"4.10.860.120","chopping":"17-87_304-349_376-422","consensus_level":"medium","plddt":86.1612,"start":17,"end":422},{"cath_id":"-","chopping":"92-208_262-296","consensus_level":"medium","plddt":81.1764,"start":92,"end":296},{"cath_id":"2.40.40.20","chopping":"437-617","consensus_level":"medium","plddt":90.8525,"start":437,"end":617},{"cath_id":"1.10.274.100","chopping":"634-716_733-796","consensus_level":"high","plddt":91.3027,"start":634,"end":796},{"cath_id":"1.10.132.30","chopping":"801-954","consensus_level":"high","plddt":87.4621,"start":801,"end":954},{"cath_id":"3.30.70.2850","chopping":"1289-1362_1497-1555","consensus_level":"medium","plddt":83.1515,"start":1289,"end":1555}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95602","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95602-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95602-F1-predicted_aligned_error_v6.png","plddt_mean":80.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLR1A","jax_strain_url":"https://www.jax.org/strain/search?query=POLR1A"},"sequence":{"accession":"O95602","fasta_url":"https://rest.uniprot.org/uniprotkb/O95602.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95602/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95602"}},"corpus_meta":[{"pmid":"9539419","id":"PMC_9539419","title":"Genetic analysis of yeast RPA1 reveals its multiple functions in DNA metabolism.","date":"1998","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9539419","citation_count":166,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15965476","id":"PMC_15965476","title":"Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15965476","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32201722","id":"PMC_32201722","title":"Global crotonylome reveals CDYL-regulated RPA1 crotonylation in homologous recombination-mediated DNA repair.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32201722","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2830265","id":"PMC_2830265","title":"RPA190, the gene coding for the largest subunit of yeast RNA polymerase A.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2830265","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18469000","id":"PMC_18469000","title":"Cellular functions of human RPA1. Multiple roles of domains in replication, repair, and checkpoints.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18469000","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11340166","id":"PMC_11340166","title":"Rfc4 interacts with Rpa1 and is required for both DNA replication and DNA damage checkpoints in Saccharomyces cerevisiae.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11340166","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26403191","id":"PMC_26403191","title":"PTEN regulates RPA1 and protects DNA replication forks.","date":"2015","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/26403191","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3103101","id":"PMC_3103101","title":"Structural analysis of the Drosophila rpA1 gene, a member of the eucaryotic 'A' type ribosomal protein family.","date":"1987","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/3103101","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28854354","id":"PMC_28854354","title":"PCAF/GCN5-Mediated Acetylation of RPA1 Promotes Nucleotide Excision Repair.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28854354","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25913037","id":"PMC_25913037","title":"Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25913037","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18441258","id":"PMC_18441258","title":"Immunolocalization of Kim-1, RPA-1, and RPA-2 in kidney of gentamicin-, mercury-, or chromium-treated rats: relationship to renal distributions of iNOS and nitrotyrosine.","date":"2008","source":"Toxicologic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18441258","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30309964","id":"PMC_30309964","title":"RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE-dependent repression.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30309964","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19586055","id":"PMC_19586055","title":"Physical interaction between replication protein A (RPA) and MRN: involvement of RPA2 phosphorylation and the N-terminus of RPA1.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19586055","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34767620","id":"PMC_34767620","title":"Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34767620","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29024939","id":"PMC_29024939","title":"Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1.","date":"2017","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29024939","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28854355","id":"PMC_28854355","title":"UV-Induced RPA1 Acetylation Promotes Nucleotide Excision Repair.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28854355","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9275237","id":"PMC_9275237","title":"Expression of an ortholog of replication protein A1 (RPA1) is induced by gibberellin in deepwater rice.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9275237","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3054507","id":"PMC_3054507","title":"Isolation and characterization of temperature-sensitive mutations in RPA190, the gene encoding the largest subunit of RNA polymerase I from Saccharomyces cerevisiae.","date":"1988","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3054507","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2183018","id":"PMC_2183018","title":"Conditional expression of RPA190, the gene encoding the largest subunit of yeast RNA polymerase I: effects of decreased rRNA synthesis on ribosomal protein synthesis.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2183018","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19535489","id":"PMC_19535489","title":"Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine.","date":"2009","source":"Toxicologic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19535489","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14642562","id":"PMC_14642562","title":"MEC1-dependent phosphorylation of yeast RPA1 in vitro.","date":"2003","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/14642562","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26551315","id":"PMC_26551315","title":"Metalaxyl Resistance in Phytophthora infestans: Assessing Role of RPA190 Gene and Diversity Within Clonal Lineages.","date":"2015","source":"Phytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/26551315","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9241242","id":"PMC_9241242","title":"Cell cycle regulation of RPA1 transcript levels in the trypanosomatid Crithidia fasciculata.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9241242","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27208176","id":"PMC_27208176","title":"miR-30a can inhibit DNA replication by targeting RPA1 thus slowing cancer cell proliferation.","date":"2016","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27208176","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29244155","id":"PMC_29244155","title":"Differential RPA-1 and RAD-51 recruitment in vivo throughout the C. elegans germline, as revealed by laser microirradiation.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29244155","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28051070","id":"PMC_28051070","title":"Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A.","date":"2017","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/28051070","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21901111","id":"PMC_21901111","title":"Increased RPA1 gene dosage affects genomic stability potentially contributing to 17p13.3 duplication syndrome.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21901111","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30144445","id":"PMC_30144445","title":"RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30144445","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29477843","id":"PMC_29477843","title":"Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29477843","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36721037","id":"PMC_36721037","title":"Loss of RPA1 Impairs Peripheral T Cell Homeostasis and Exacerbates Inflammatory Damage through Triggering T Cell Necroptosis.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36721037","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31849122","id":"PMC_31849122","title":"Rpa1 mediates an immune response to avrRpm1Psa and confers resistance against Pseudomonas syringae pv. actinidiae.","date":"2020","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31849122","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29457681","id":"PMC_29457681","title":"Analysis of RPA190 revealed multiple positively selected mutations associated with metalaxyl resistance in Phytophthora infestans.","date":"2018","source":"Pest management science","url":"https://pubmed.ncbi.nlm.nih.gov/29457681","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9726980","id":"PMC_9726980","title":"Nuleclear extracts of Crithidia fasciculata contain a factor(s) that binds to the 5'-untranslated regions of TOP2 and RPA1 mRNAs containing sequences required for their cell cycle regulation.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9726980","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30923916","id":"PMC_30923916","title":"Genetic variants in RPA1 associated with the response to oxaliplatin-based chemotherapy in colorectal cancer.","date":"2019","source":"Journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/30923916","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32849834","id":"PMC_32849834","title":"Radioresistance, DNA Damage and DNA Repair in Cells With Moderate Overexpression of RPA1.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32849834","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35830798","id":"PMC_35830798","title":"RPA1 controls chromatin architecture and maintains lipid metabolic homeostasis.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35830798","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8020972","id":"PMC_8020972","title":"High-resolution genomic mapping of the three human replication protein A genes (RPA1, RPA2, and RPA3).","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8020972","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23388105","id":"PMC_23388105","title":"The natural absence of RPA1N domain did not impair Leishmania amazonensis RPA-1 participation in DNA damage response and telomere protection.","date":"2013","source":"Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/23388105","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22257160","id":"PMC_22257160","title":"Physical and functional interactions of Caenorhabditis elegans WRN-1 helicase with RPA-1.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22257160","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37075751","id":"PMC_37075751","title":"POLR1A variants underlie phenotypic heterogeneity in craniofacial, neural, and cardiac anomalies.","date":"2023","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37075751","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28173122","id":"PMC_28173122","title":"RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repair.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28173122","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25451229","id":"PMC_25451229","title":"RPA-1 from Leishmania amazonensis (LaRPA-1) structurally differs from other eukaryote RPA-1 and interacts with telomeric DNA via its N-terminal OB-fold domain.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/25451229","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15620706","id":"PMC_15620706","title":"Loss of RPA1 induces Chk2 phosphorylation through a caffeine-sensitive pathway.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15620706","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26824734","id":"PMC_26824734","title":"RPA1 expression in esophageal carcinoma and its influence on radiosensitivity of esophageal carcinoma TE-1 cells.","date":"2015","source":"Panminerva medica","url":"https://pubmed.ncbi.nlm.nih.gov/26824734","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32222548","id":"PMC_32222548","title":"A multi-approach analysis highlights the relevance of RPA-1 as a telomere end-binding protein (TEBP) in Leishmania amazonensis.","date":"2020","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/32222548","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32862594","id":"PMC_32862594","title":"Replication Protein A (RPA1, RPA2 and RPA3) expression in gastric cancer: correlation with clinicopathologic parameters and patients' survival.","date":"2020","source":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32862594","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32860897","id":"PMC_32860897","title":"The RPA190-pc gene participates in the regulation of metalaxyl sensitivity, pathogenicity and growth in Phytophthora capsici.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32860897","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40669210","id":"PMC_40669210","title":"POLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis.","date":"2025","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/40669210","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36917474","id":"PMC_36917474","title":"A homozygous POLR1A variant causes leukodystrophy and affects protein homeostasis.","date":"2023","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36917474","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37869077","id":"PMC_37869077","title":"Germline landscape of RPA1, RPA2 and RPA3 variants in pediatric malignancies: identification of RPA1 as a novel cancer predisposition candidate gene.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37869077","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38306819","id":"PMC_38306819","title":"Cinchophen induces RPA1 related DNA damage and apoptosis to impair ENS development of zebrafish.","date":"2024","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/38306819","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37463174","id":"PMC_37463174","title":"UBQLN1 deficiency mediates telomere shortening and IPF through interacting with RPA1.","date":"2023","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37463174","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40834068","id":"PMC_40834068","title":"RPA1 protects DNA damage-induced PANoptosis in limb development.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40834068","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37200372","id":"PMC_37200372","title":"Comprehensive mutational analysis of the checkpoint signaling function of Rpa1/Ssb1 in fission yeast.","date":"2023","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37200372","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39859385","id":"PMC_39859385","title":"In and out of Replication Stress: PCNA/RPA1-Based Dynamics of Fork Stalling and Restart in the Same Cell.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39859385","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40593477","id":"PMC_40593477","title":"Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/40593477","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39125953","id":"PMC_39125953","title":"CDC20 Holds Novel Regulation Mechanism in RPA1 during Different Stages of DNA Damage to Induce Radio-Chemoresistance.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39125953","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39660144","id":"PMC_39660144","title":"Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39660144","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34355021","id":"PMC_34355021","title":"Remote Homology Detection Identifies a Eukaryotic RPA DBD-C-like DNA Binding Domain as a Conserved Feature of Archaeal Rpa1-Like Proteins.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/34355021","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41271679","id":"PMC_41271679","title":"HAT1 functions as a lactyltransferase and mediates RPA1 lactylation to promote DNA repair and radioresistance in lung adenocarcinoma.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41271679","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10619604","id":"PMC_10619604","title":"Molecular cloning, developmental expression, and cellular localization of the 70-kDa RPA-1 subunit of Drosophila melanogaster.","date":"1999","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10619604","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41120267","id":"PMC_41120267","title":"Phosphorylation of RNF213 by ATM-mediated ubiquitination of RPA1 regulates homologous recombination repair and chemosensitivity.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41120267","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40630228","id":"PMC_40630228","title":"Role and mechanism of RPA1 in the development and progression of glioma.","date":"2025","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40630228","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41694603","id":"PMC_41694603","title":"HAT1 as a Lactyltransferase to Promote DNA Repair Through RPA1 Lactylation in Glioblastoma.","date":"2026","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41694603","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36945624","id":"PMC_36945624","title":"Comprehensive mutational analysis of the checkpoint signaling function of Rpa1/Ssb1 in fission yeast.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36945624","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41427347","id":"PMC_41427347","title":"Oncometabolite fumarate impairs ATR-CHK1 signaling by succinating RPA1 in Fumarate Hydratase-deficient renal cell carcinoma cells.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41427347","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41997286","id":"PMC_41997286","title":"RNF185 orchestrates replication fork restart and homologous recombination through temporal RPA1 ubiquitination switching.","date":"2026","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/41997286","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33847961","id":"PMC_33847961","title":"Quantifying the Affinity of Trypanosoma cruzi RPA-1 to the Single-Stranded DNA Overhang of the Telomere Using Surface Plasmon Resonance.","date":"2021","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/33847961","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28854353","id":"PMC_28854353","title":"Feeling Stressed under the Sun? RPA1 Acetylation to the Rescue.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28854353","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41318151","id":"PMC_41318151","title":"RPA1, RFC1, and POLE Expression in Clear Cell Renal Cell Carcinoma: Immune and Clinical Relevance.","date":"2025","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/41318151","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41677375","id":"PMC_41677375","title":"Ascites circRNA ASCOR Drives Platinum Resistance of High-Grade Serous Ovarian Cancer by Facilitating RPA1 Nuclear Translocation.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41677375","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34816659","id":"PMC_34816659","title":"[Effects of RPA1 down-regulation on the invasion and migration and cell cycle of human nasopharyngeal carcinoma CNE-2R cells with radio resistance].","date":"2021","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34816659","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14743216","id":"PMC_14743216","title":"A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.","date":"2004","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14743216","citation_count":841,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16618798","id":"PMC_16618798","title":"Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16618798","citation_count":478,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17643375","id":"PMC_17643375","title":"Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17643375","citation_count":367,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17620599","id":"PMC_17620599","title":"Functional specialization of beta-arrestin interactions revealed by proteomic analysis.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17620599","citation_count":360,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12446911","id":"PMC_12446911","title":"A kinetic framework for a mammalian RNA polymerase in vivo.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12446911","citation_count":345,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28611215","id":"PMC_28611215","title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28611215","citation_count":282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24207024","id":"PMC_24207024","title":"Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24207024","citation_count":167,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32416067","id":"PMC_32416067","title":"Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32416067","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11250903","id":"PMC_11250903","title":"hRRN3 is essential in the SL1-mediated recruitment of RNA Polymerase I to rRNA gene promoters.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11250903","citation_count":155,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26399832","id":"PMC_26399832","title":"Cell-fate determination by ubiquitin-dependent regulation of translation.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26399832","citation_count":149,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22586326","id":"PMC_22586326","title":"Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.","date":"2012","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/22586326","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23150253","id":"PMC_23150253","title":"Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes.","date":"2013","source":"Sub-cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23150253","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34842,"output_tokens":2337,"usd":0.069791},"stage2":{"model":"claude-opus-4-6","input_tokens":5384,"output_tokens":2280,"usd":0.12588},"total_usd":0.459095,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":46436,"output_tokens":4541,"usd":0.103711},"round2_rules_fired":"R2,R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7525,"output_tokens":2754,"usd":0.159713}},"stage1_raw":"Looking at the corpus, I need to identify which papers are about the human/mammalian POLR1A gene (largest subunit of RNA Polymerase I) versus papers about RPA1 (Replication Protein A 1, a single-stranded DNA binding protein). These are two completely different genes that appear in this corpus.\n\n- **POLR1A** (RNA Polymerase I largest subunit, ~190 kDa, also called RPA194 or A190): Papers [4], [10], [18], [19], [26], [40], [48], [49]\n- **RPA1** (Replication Protein A 70kDa subunit, ssDNA binding): Papers [1]-[3], [5]-[9], [12]-[17], [21], [24]-[25], [27]-[30], etc.\n\nThe query gene is **POLR1A** (RNA Polymerase I subunit A). I must focus only on papers about this gene.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"The yeast RPA190 gene encodes the largest subunit (A190) of RNA Polymerase I and is essential for cell viability; gene disruption abolishes growth. Sequence analysis revealed conserved homology regions (I–VI) shared with E. coli beta' and other eukaryotic RNA polymerase large subunits, including a zinc-binding motif in region I. The A190 subunit lacks the heptapeptide CTD repeat present in RNA Pol II largest subunit.\",\n      \"method\": \"Gene disruption, Southern hybridization, nuclease S1 mapping, amino acid sequence analysis and dot matrix comparison\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — gene disruption with essential viability phenotype, structural sequence analysis replicated across polymerase subunits\",\n      \"pmids\": [\"2830265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Temperature-sensitive mutations in yeast RPA190 (POLR1A ortholog) impair rRNA gene transcription specifically: at the nonpermissive temperature, rRNA synthesis is decreased while 5S RNA transcription is relatively unaffected, and RNA Polymerase I purified from mutant strains is deficient in vitro. Mutations cluster in conserved region I (putative zinc-binding region) and other conserved segments.\",\n      \"method\": \"In vitro mutagenesis, plasmid shuffle, pulse-labeling of RNA, partial purification of RNA Pol I and in vitro transcription assay, fine-structure mapping and sequencing\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro transcription assay combined with in vivo RNA labeling and mutant sequencing in single rigorous study\",\n      \"pmids\": [\"3054507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Conditional depletion of the yeast RPA190 (POLR1A ortholog) product by placing it under galactose promoter control demonstrated that loss of RNA Pol I activity leads to preferential reduction in ribosomal RNA synthesis; ribosomal protein accumulation then decreases to match the reduced rRNA synthesis rate, primarily through enhanced degradation of excess ribosomal proteins rather than reduced translation.\",\n      \"method\": \"Conditional (GAL promoter) expression system, pulse-chase labeling of proteins, Northern blot analysis, polysome analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined molecular phenotype (rRNA and ribosomal protein synthesis), multiple orthogonal readouts\",\n      \"pmids\": [\"2183018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Heterozygous mutations in POLR1A cause acrofacial dysostosis, Cincinnati type in humans. In zebrafish, polr1a loss of function leads to perturbed ribosome biogenesis, p53-dependent cell death, and deficiency of neural-crest-derived skeletal precursor cells, resulting in craniofacial anomalies.\",\n      \"method\": \"Human genetics (heterozygous mutation identification), zebrafish loss-of-function model, ribosome biogenesis assay, p53 pathway analysis, cell death quantification\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in vivo (zebrafish) with defined cellular phenotype (neural crest deficiency via p53-dependent apoptosis) corroborated by human genetic findings\",\n      \"pmids\": [\"25913037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A homozygous missense mutation in POLR1A (p.Ser934Leu) causes a complex neurodegenerative leukodystrophy. Functional verification showed decreased nucleolar RPA194 protein in skin fibroblasts of affected brothers, consistent with loss of RNA Polymerase I function.\",\n      \"method\": \"Linkage analysis, exome sequencing, immunofluorescence of nucleolar RPA194 in patient fibroblasts, segregation analysis\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization/expression of POLR1A protein in patient cells linked to disease; single study with moderate methods\",\n      \"pmids\": [\"28051070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"An allelic series of heterozygous POLR1A variants shows variable effects on ribosomal RNA synthesis and nucleolar morphology in vitro. Conditional knockout of Polr1a in specific developmental lineages (neural crest cells, second heart field, forebrain precursors) in mice causes cell-autonomous apoptosis and lineage-specific embryonic malformations, establishing that POLR1A is required for ribosome biogenesis in each of these cell types.\",\n      \"method\": \"CRISPR-Cas9 knock-in of human variants in mice, in vitro rRNA synthesis assay, nucleolar morphology assessment, conditional mutagenesis with Cre drivers, apoptosis quantification\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal in vitro and in vivo methods, allelic series, conditional KO with defined cell-autonomous apoptosis phenotype\",\n      \"pmids\": [\"37075751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A homozygous POLR1A missense variant (p.Thr642Asn) causes aberrant rRNA processing and degradation, abnormal nucleolar homeostasis, abnormal protein homeostasis, and endoplasmic reticulum stress responses in patient fibroblasts, establishing the disease mechanism of POLR1A-related leukodystrophy.\",\n      \"method\": \"Extensive in vitro experiments in patient fibroblasts: rRNA processing assays, nucleolar morphology, proteomics, ER stress markers\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal in vitro methods (rRNA processing, proteomics, ER stress) in patient-derived cells\",\n      \"pmids\": [\"36917474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"POLR1A controls TFAM expression via the transcription factor ATF4, and this POLR1A-ATF4-TFAM axis inhibits mitophagy and limits mitophagy-dependent labile Fe2+ release, thereby preventing Fe2+-driven lipid peroxidation and ferroptosis. Disruption of POLR1A leads to Fe2+ accumulation and increased sensitivity to ferroptosis inducers.\",\n      \"method\": \"POLR1A inhibition (CX-5461), TFAM regulation assays, mitophagy flux assays, iron quantification, lipid peroxidation assays, in vitro and in vivo ferroptosis assays\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway (POLR1A-ATF4-TFAM-mitophagy-iron) established with multiple functional readouts; single lab study\",\n      \"pmids\": [\"40669210\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLR1A encodes the largest catalytic subunit of RNA Polymerase I, is essential for ribosomal RNA (rRNA) gene transcription and ribosome biogenesis, and its loss causes p53-dependent cell death in neural crest and other developmental lineages; beyond its canonical transcriptional role, POLR1A also regulates mitochondrial homeostasis through an ATF4-TFAM axis that controls mitophagy and intracellular iron levels, thereby influencing ferroptosis resistance.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\nPOLR1A encodes the largest subunit (RPA194/A190) of RNA Polymerase I. Papers about RPA1 (Replication Protein A 1, a single-stranded DNA binding protein) are ALIAS COLLISIONS — a different gene entirely. Papers about plant/oomycete RPA190 are SYMBOL COLLISIONS. Papers about Drosophila ribosomal protein rpA1 are SYMBOL COLLISIONS.\n\n**KEEP (canonical POLR1A = largest subunit of RNA Pol I):**\n- [4] RPA190 yeast gene — KEEP (yeast ortholog of POLR1A)\n- [18] Temperature-sensitive mutations in RPA190 yeast — KEEP\n- [19] Conditional expression RPA190 yeast — KEEP\n- [10] POLR1A dysfunction → acrofacial dysostosis — KEEP\n- [26] Severe neurodegenerative disease with homozygous POLR1A mutation — KEEP\n- [40] POLR1A variants → craniofacial, neural, cardiac anomalies — KEEP\n- [48] POLR1A inhibits ferroptosis via TFAM/mitophagy — KEEP\n- [49] Homozygous POLR1A variant → leukodystrophy — KEEP\n- Additional [15] SIRT7 activator of RNA Pol I — KEEP (mentions Pol I machinery)\n- Additional [20] Kinetic framework mammalian RNA Pol I — KEEP\n- Additional [25] PAF53 deacetylation by SIRT7 — KEEP\n- Additional [27] hRRN3 recruits RNA Pol I — KEEP\n- Additional [29] SIRT7 interaction with RNA Pol I — KEEP\n- Additional [30] Basic mechanisms RNA Pol I transcription — KEEP\n\n**EXCLUDE (RPA1 = Replication Protein A 1, alias collision):**\nPapers [1],[2],[3],[5],[6],[7],[8],[9],[11],[12],[13],[14],[15-paper],[16],[17],[21],[23],[24],[25-paper],[27-paper],[28],[29-paper],[30-paper],[33],[34],[35],[36],[37],[38],[39],[41],[42],[43],[44],[45],[46],[50],[51],[52],[53],[54],[55],[56],[57],[58],[59],[60],[61],[62],[63],[64],[65],[66],[67],[68],[69],[70],[71],[72]\n\n**EXCLUDE (plant/oomycete symbol collision):**\nPapers [22],[31],[32],[47]\n\n**EXCLUDE (Drosophila ribosomal protein):**\nPaper [8]\n\nNow extracting from KEPT papers:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"The yeast RPA190 gene encodes the largest subunit (A190, 186 kDa) of RNA polymerase I; the gene is unique in the haploid genome and essential for cell viability. Sequence analysis revealed conserved homology regions (I–VI) shared with E. coli beta' and the largest subunits of RNA Pol II and Pol III, including a conserved N-terminal zinc-binding (DNA-binding) motif. A190 lacks the heptapeptide CTD repeat present in the Pol II large subunit and contains two unique hydrophilic insertion domains.\",\n      \"method\": \"Gene isolation, Southern hybridization, gene disruption, nuclease S1 mapping, DNA sequencing, dot-matrix sequence comparison\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — gene disruption (essential viability) + full sequence characterization; foundational paper, 101 citations\",\n      \"pmids\": [\"2830265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Temperature-sensitive mutations in yeast RPA190 (the POLR1A ortholog) cause defective rRNA accumulation and reduced RNA polymerase I activity in vitro at the non-permissive temperature, while 5S RNA synthesis is relatively unaffected. Fine-structure mapping showed that two ts mutations (rpa190-1 and rpa190-5) cluster in the conserved zinc-binding region I; rpa190-3 maps to a previously unidentified highly conserved segment between regions III and IV and appears to reduce enzyme levels; rpa190-2 creates a UGA nonsense codon.\",\n      \"method\": \"In vitro hydroxylamine mutagenesis, plasmid shuffle, pulse-labeling of RNA, partial purification of RNA Pol I and in vitro assay, fine-structure mapping, DNA sequencing\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzyme activity assay combined with mutagenesis and in vivo RNA labeling\",\n      \"pmids\": [\"3054507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Conditional depletion of RPA190 (yeast POLR1A ortholog) via galactose-promoter control causes preferential loss of rRNA synthesis; ribosomal protein accumulation subsequently decreases to match the reduced rRNA synthesis rate, largely through post-translational degradation of excess r-proteins rather than transcriptional repression of r-protein mRNAs. An exception is L32 pre-mRNA splicing, which is feedback-inhibited when rRNA decreases.\",\n      \"method\": \"Galactose-promoter conditional expression system, pulse-chase labeling, polysome analysis, Northern blotting\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined molecular phenotype, multiple orthogonal readouts\",\n      \"pmids\": [\"2183018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"hRRN3 defines a transcriptionally competent subpopulation of RNA Polymerase I (Pol I beta) and is required for Pol I recruitment to rDNA promoters. hRRN3 physically interacts with the SL1 subunits TAF(I)110 and TAF(I)63; blocking this interaction prevents Pol I recruitment to the promoter. hRRN3 can also be found in Pol I holoenzyme complexes capable of autonomous transcription.\",\n      \"method\": \"Affinity purification, co-immunoprecipitation, in vitro transcription assay, chromatin immunoprecipitation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstituted transcription assay + reciprocal co-IP + ChIP; 155 citations\",\n      \"pmids\": [\"11250903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In living cells, mammalian RNA Polymerase I components are recruited to ribosomal genes as distinct subunits and assembly occurs via metastable intermediates rather than as a preformed holoenzyme. In vivo elongation time of the polymerase was determined by computational modeling of FRAP data; incorporation of components into the assembling polymerase is inefficient.\",\n      \"method\": \"In vivo fluorescence microscopy (FRAP), computational modeling of imaging data, stable cell lines expressing GFP-tagged Pol I subunits\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — quantitative live-cell FRAP with computational kinetic modeling; 345 citations\",\n      \"pmids\": [\"12446911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SIRT7 is a nucleolar protein that associates with RNA Polymerase I at active rRNA genes. Overexpression of SIRT7 increases Pol I-mediated transcription; knockdown of SIRT7 or inhibition of its catalytic activity reduces Pol I association with rDNA and decreases Pol I transcription. SIRT7 depletion stops cell proliferation and triggers apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), RNAi knockdown, overexpression, cell proliferation and apoptosis assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP + ChIP + functional KD/OE; 478 citations\",\n      \"pmids\": [\"16618798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Functional proteomics of SIRT7 confirmed its interaction with RNA Pol I and upstream binding factor (UBF) and revealed association with chromatin remodeling complexes (B-WICH complex members: Mybbp1a, WSTF, SNF2h). SIRT7 knockdown reduces RNA Pol I protein levels (but not mRNA), implicating SIRT7 in stabilization of the Pol I machinery.\",\n      \"method\": \"EGFP-tagged SIRT7 affinity purification, mass spectrometry, SRM-like quantitative proteomics with SILAC, confocal microscopy, reciprocal immunoaffinity precipitation, siRNA knockdown\",\n      \"journal\": \"Molecular & cellular proteomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — comprehensive proteomic interaction map with multiple validation methods; 145 citations\",\n      \"pmids\": [\"22586326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SIRT7 deacetylates PAF53 (a subunit of RNA Polymerase I) at lysine 373; acetylation of PAF53 by CBP reduces Pol I–rDNA occupancy and transcription, while SIRT7-mediated deacetylation promotes it. Under stress, SIRT7 is released from nucleoli in an RNA-dependent manner, leading to PAF53 hyperacetylation and reduced Pol I transcription. SIRT7 nucleolar retention requires binding to nascent pre-rRNA.\",\n      \"method\": \"In vitro deacetylation assay, acetylation-site mutagenesis, ChIP, RNA immunoprecipitation, fluorescence microscopy, stress-induced SIRT7 relocalization assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay + mutagenesis + ChIP + mechanistic RNA-binding studies; 167 citations\",\n      \"pmids\": [\"24207024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RNA Polymerase I-specific transcription factors (including SL1/TIF-IB, UBF, RRN3/TIF-IA) guide Pol I to the rDNA promoter and contribute to multiple rounds of initiation, promoter escape, elongation, and termination. Accessory factors integrate transcriptional activity with metabolic demands, and rDNA chromatin organization/epigenetic state impinges on Pol I output. Deregulated Pol I transcription is a feature of cancer.\",\n      \"method\": \"Review integrating biochemical reconstitution, ChIP, and mutagenesis studies from multiple labs\",\n      \"journal\": \"Sub-cellular biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — review synthesizing decades of reconstitution and mechanistic studies; 142 citations\",\n      \"pmids\": [\"23150253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Heterozygous mutations in POLR1A (encoding the largest subunit of RNA Polymerase I, RPA194) cause acrofacial dysostosis, Cincinnati type. polr1a mutant zebrafish exhibit cranioskeletal anomalies; polr1a loss of function leads to perturbed ribosome biogenesis, p53-dependent cell death, and deficiency of neural-crest-derived skeletal precursor cells, resulting in craniofacial anomalies.\",\n      \"method\": \"Human exome sequencing, zebrafish polr1a morpholino/mutant model, ribosome biogenesis assays, p53 pathway analysis, skeletal staining\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo zebrafish model with defined molecular phenotype (ribosome biogenesis, p53 apoptosis) + human genetics\",\n      \"pmids\": [\"25913037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A homozygous missense variant in POLR1A (c.2801C>T, p.Ser934Leu), encoding RPA194 (the largest subunit of RNA Pol I), causes complex leukodystrophy with neurodegeneration in humans. Skin fibroblasts from affected individuals showed decreased nucleolar RPA194 protein, linking POLR1A dysfunction to disrupted nucleolar function and leukodystrophy.\",\n      \"method\": \"Linkage analysis, exome sequencing, immunofluorescence of RPA194 in patient fibroblasts, segregation analysis\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human genetics + functional validation in patient cells (single lab, limited mechanistic depth)\",\n      \"pmids\": [\"28051070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Heterozygous pathogenic POLR1A variants cause a phenotypic spectrum including craniofacial anomalies, neurodevelopmental abnormalities, and structural cardiac defects. In vitro studies showed that individual variants have variable effects on ribosomal RNA synthesis and nucleolar morphology. Conditional mutagenesis in mice demonstrated that loss of Polr1a in neural crest cells, second heart field, or forebrain precursors causes cell-autonomous apoptosis and embryonic malformations in the corresponding tissues.\",\n      \"method\": \"Human cohort sequencing, in vitro rRNA synthesis assays, nucleolar morphology analysis, CRISPR-Cas9 knock-in mice, conditional (Cre-lox) mutagenesis in specific developmental lineages, embryonic phenotyping\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — allelic series in vitro + multiple conditional mouse KO lines with defined cell-autonomous apoptosis phenotypes\",\n      \"pmids\": [\"37075751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A homozygous POLR1A missense variant (p.Thr642Asn) causes hypomyelinating leukodystrophy with cerebellar atrophy. In vitro experiments in patient fibroblasts demonstrated that mutant POLR1A leads to aberrant rRNA processing and degradation, abnormal nucleolar homeostasis, abnormal protein homeostasis, and endoplasmic reticulum stress responses.\",\n      \"method\": \"Exome sequencing, patient fibroblast culture, rRNA processing assays, nucleolar morphology, proteomics, ER stress marker analysis\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal in vitro mechanistic assays in patient-derived cells\",\n      \"pmids\": [\"36917474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"POLR1A (the catalytic subunit of RNA Polymerase I) controls TFAM expression via the transcription factor ATF4, and this POLR1A–ATF4–TFAM axis inhibits mitophagy and limits mitophagy-dependent labile Fe2+ release, thereby preventing Fe2+-driven lipid peroxidation and ferroptosis. Disruption of POLR1A or TFAM leads to Fe2+ accumulation and increased sensitivity to ferroptosis inducers. CX-5461 (a Pol I inhibitor) synergizes with GPX4 blockade to induce ferroptotic cell death in vitro and in vivo.\",\n      \"method\": \"POLR1A knockdown/inhibition (CX-5461), TFAM expression analysis, mitophagy assays, labile iron pool measurements, lipid peroxidation assays, GPX4 combination experiments, in vivo xenograft models\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional KD with defined mechanistic pathway (POLR1A→ATF4→TFAM→mitophagy→Fe2+→ferroptosis), single lab\",\n      \"pmids\": [\"40669210\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLR1A encodes the largest catalytic subunit (RPA194/A190) of RNA Polymerase I, which is essential for rDNA transcription and ribosome biogenesis; it is recruited to rDNA promoters via RRN3–SL1 interactions, its activity is regulated by SIRT7-mediated deacetylation of the associated subunit PAF53, and loss-of-function variants cause p53-dependent apoptosis of neural crest cells (producing craniofacial dysostosis), leukodystrophy via aberrant rRNA processing and ER stress, while a newly identified nucleolar-mitochondrial axis links POLR1A to ATF4-TFAM-dependent mitophagy and ferroptosis resistance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POLR1A encodes the largest catalytic subunit of RNA Polymerase I and is essential for ribosomal RNA transcription and ribosome biogenesis across eukaryotes. The subunit harbors conserved regions (I–VI) shared with other multi-subunit RNA polymerase large subunits, including a zinc-binding motif critical for catalytic activity; mutations in these regions abolish rRNA synthesis while leaving RNA Pol II and Pol III transcription intact [PMID:2830265, PMID:3054507]. Loss of POLR1A reduces rRNA output, triggers excess ribosomal protein degradation, causes nucleolar disruption and ER stress, and activates p53-dependent apoptosis in susceptible developmental lineages—neural crest cells, second heart field, and forebrain precursors—explaining why heterozygous POLR1A mutations cause acrofacial dysostosis (Cincinnati type) and homozygous missense variants cause leukodystrophy [PMID:25913037, PMID:37075751, PMID:36917474, PMID:28051070]. Beyond rRNA transcription, POLR1A sustains TFAM expression via ATF4, thereby restraining mitophagy-dependent labile Fe²⁺ release and conferring resistance to ferroptosis [PMID:40669210].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Establishing that POLR1A (RPA190) encodes the essential largest subunit of RNA Pol I resolved which gene product provides the catalytic core of the rDNA transcription machinery and showed it is structurally related to, yet distinct from, the largest subunits of Pol II and Pol III.\",\n      \"evidence\": \"Gene disruption of yeast RPA190 with lethality; sequence comparison revealing conserved regions I–VI and a zinc-binding motif; temperature-sensitive mutants with selective rRNA synthesis defects and defective Pol I in vitro\",\n      \"pmids\": [\"2830265\", \"3054507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how individual conserved regions contribute to catalysis was not resolved\",\n        \"Whether mammalian POLR1A is similarly essential was not tested\"\n      ]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Conditional depletion of yeast RPA190 demonstrated that loss of Pol I activity primarily reduces rRNA output and that cells compensate by degrading excess ribosomal proteins rather than reducing their translation, establishing the downstream proteostatic consequence of Pol I loss.\",\n      \"evidence\": \"GAL-promoter conditional expression system with pulse-chase protein labeling, Northern blots, and polysome analysis in yeast\",\n      \"pmids\": [\"2183018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether p53 or other stress pathways are engaged in metazoan cells upon Pol I loss was unknown\",\n        \"Mechanism of selective ribosomal protein degradation was not identified\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connecting heterozygous POLR1A mutations to acrofacial dysostosis Cincinnati type and showing that polr1a loss in zebrafish causes p53-dependent apoptosis specifically in neural crest cells established POLR1A haploinsufficiency as a ribosomopathy with selective developmental vulnerability.\",\n      \"evidence\": \"Human mutation identification combined with zebrafish loss-of-function models, ribosome biogenesis assays, and p53 pathway analysis\",\n      \"pmids\": [\"25913037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Why neural crest cells are selectively vulnerable to reduced Pol I activity was not mechanistically explained\",\n        \"Whether other developmental lineages are similarly affected was untested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of a homozygous POLR1A missense mutation causing leukodystrophy, with reduced nucleolar RPA194, extended the disease spectrum from craniofacial to neurodegenerative phenotypes and showed that biallelic loss-of-function variants are compatible with survival but cause CNS degeneration.\",\n      \"evidence\": \"Linkage analysis, exome sequencing, and immunofluorescence of nucleolar POLR1A in patient fibroblasts\",\n      \"pmids\": [\"28051070\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single family study; independent replication in additional families was lacking\",\n        \"Downstream molecular pathology in neurons was not characterized\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"An allelic series and lineage-specific conditional knockouts in mice demonstrated that POLR1A is cell-autonomously required for ribosome biogenesis in neural crest, second heart field, and forebrain precursors, with graded effects on rRNA synthesis and nucleolar morphology depending on variant severity.\",\n      \"evidence\": \"CRISPR knock-in of human variants, in vitro rRNA synthesis assays, conditional mutagenesis with multiple Cre drivers, apoptosis quantification in mice\",\n      \"pmids\": [\"37075751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis for tissue-selective sensitivity to partial Pol I loss remains unresolved\",\n        \"Whether therapeutic rRNA augmentation can rescue developmental phenotypes was not tested\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mechanistic dissection in patient fibroblasts revealed that a homozygous POLR1A variant causes aberrant rRNA processing and degradation, disrupted nucleolar homeostasis, altered protein homeostasis, and ER stress, defining the cellular pathology of POLR1A-related leukodystrophy.\",\n      \"evidence\": \"rRNA processing assays, nucleolar morphology analysis, proteomics, and ER stress marker quantification in patient-derived fibroblasts\",\n      \"pmids\": [\"36917474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ER stress is the primary driver of neurodegeneration or secondary to ribosome loss is unclear\",\n        \"In vivo validation in CNS tissue was not performed\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Revealing that POLR1A regulates TFAM expression through ATF4, thereby restraining mitophagy-dependent Fe²⁺ release and ferroptosis, uncovered a non-canonical role for POLR1A in mitochondrial homeostasis and iron metabolism beyond rRNA transcription.\",\n      \"evidence\": \"CX-5461-mediated POLR1A inhibition, TFAM regulation assays, mitophagy flux analysis, iron quantification, lipid peroxidation and ferroptosis assays in vitro and in vivo\",\n      \"pmids\": [\"40669210\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab study; independent replication needed\",\n        \"Whether ATF4-TFAM axis operates downstream of POLR1A in developmental ribosomopathy contexts is unknown\",\n        \"Direct transcriptional target status of ATF4 for POLR1A (Pol I vs. indirect effect) was not resolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular basis for the tissue-selective vulnerability of neural crest, cardiac, and brain lineages to partial POLR1A loss—and whether the ferroptosis-resistance function of POLR1A contributes to developmental or neurodegenerative phenotypes—remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural model of human RNA Pol I with disease-associated POLR1A mutations\",\n        \"Relationship between the canonical rRNA synthesis defect and the non-canonical mitophagy/ferroptosis pathway is unknown\",\n        \"Therapeutic strategies targeting POLR1A-related diseases have not been tested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [4, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 1, 2, 5, 6]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 2, 5, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 5]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 6]}\n    ],\n    \"complexes\": [\n      \"RNA Polymerase I\"\n    ],\n    \"partners\": [\n      \"ATF4\",\n      \"TFAM\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"POLR1A encodes the largest catalytic subunit (RPA194/A190) of RNA Polymerase I, the enzyme dedicated to ribosomal DNA transcription and ribosome biogenesis. The subunit harbors conserved zinc-binding and catalytic regions shared with other multi-subunit RNA polymerases, is essential for cell viability, and is recruited to rDNA promoters through RRN3–SL1 interactions; its transcriptional output is positively regulated by SIRT7-mediated deacetylation of the associated subunit PAF53 [PMID:2830265, PMID:11250903, PMID:24207024]. Heterozygous loss-of-function variants in POLR1A cause acrofacial dysostosis (Cincinnati type) with p53-dependent neural crest cell apoptosis, while biallelic missense variants cause hypomyelinating leukodystrophy linked to aberrant rRNA processing and endoplasmic reticulum stress [PMID:25913037, PMID:36917474, PMID:37075751]. A nucleolar–mitochondrial signaling axis has been identified in which POLR1A controls TFAM expression via ATF4, suppressing mitophagy-dependent labile iron release and ferroptosis [PMID:40669210].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Identification of the largest Pol I subunit gene (RPA190) as a single-copy essential gene with conserved polymerase motifs established POLR1A as the catalytic core of rDNA transcription.\",\n      \"evidence\": \"Yeast gene disruption, sequencing, and dot-matrix comparison revealing conserved regions I–VI shared with Pol II/III largest subunits and E. coli β'\",\n      \"pmids\": [\"2830265\", \"3054507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No three-dimensional structure of the A190 subunit or Pol I holoenzyme at this time\",\n        \"Mechanism of promoter recognition and subunit assembly unknown\"\n      ]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Conditional depletion of RPA190 demonstrated that rRNA synthesis is rate-limiting for ribosome production and that excess ribosomal proteins are degraded post-translationally, establishing the cellular consequences of Pol I loss.\",\n      \"evidence\": \"Galactose-promoter conditional expression of RPA190 in yeast with pulse-chase labeling and polysome analysis\",\n      \"pmids\": [\"2183018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Post-translational degradation pathway for excess ribosomal proteins not identified\",\n        \"Mammalian equivalence of this regulatory coupling not yet tested\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that hRRN3 defines a transcription-competent Pol I subpopulation and bridges Pol I to the SL1 promoter-recognition complex resolved how Pol I is recruited to rDNA promoters.\",\n      \"evidence\": \"Affinity purification, reciprocal co-IP, in vitro transcription reconstitution, and ChIP in human cells\",\n      \"pmids\": [\"11250903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the RRN3–Pol I and RRN3–SL1 interfaces unknown\",\n        \"Regulation of RRN3 availability as a rate-limiting step not fully dissected\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Live-cell FRAP showed that Pol I assembles at rDNA promoters from individual subunits through metastable intermediates rather than as a preformed holoenzyme, redefining the assembly paradigm.\",\n      \"evidence\": \"GFP-tagged Pol I subunits in mammalian cell lines, quantitative FRAP with kinetic modeling\",\n      \"pmids\": [\"12446911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity and order of metastable assembly intermediates not resolved biochemically\",\n        \"Stoichiometry of on-chromatin versus off-chromatin pools unclear\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"SIRT7 was identified as a nucleolar activator of Pol I transcription that associates with active rRNA genes, linking NAD+-dependent signaling to rDNA output.\",\n      \"evidence\": \"Co-IP, ChIP at rDNA, SIRT7 knockdown and overexpression with Pol I transcription readouts\",\n      \"pmids\": [\"16618798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct enzymatic substrate of SIRT7 on the Pol I machinery not yet identified\",\n        \"Whether SIRT7 acts directly on POLR1A or on an accessory factor unknown\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"SIRT7 was shown to deacetylate PAF53 at K373, establishing a specific post-translational switch that tunes Pol I–rDNA occupancy; stress-induced SIRT7 release causes PAF53 hyperacetylation and Pol I shutdown.\",\n      \"evidence\": \"In vitro deacetylation assay, acetylation-site mutagenesis, ChIP, RNA immunoprecipitation, stress-relocalization assays\",\n      \"pmids\": [\"24207024\", \"22586326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether SIRT7 also deacetylates POLR1A/RPA194 itself not tested\",\n        \"Upstream kinase/phosphatase inputs that trigger SIRT7 nucleolar release not defined\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Human heterozygous POLR1A mutations were shown to cause acrofacial dysostosis (Cincinnati type), with zebrafish modeling demonstrating that Polr1a haploinsufficiency impairs ribosome biogenesis and induces p53-dependent apoptosis selectively in neural crest cells.\",\n      \"evidence\": \"Human exome sequencing, zebrafish morpholino/mutant, ribosome biogenesis assays, p53 pathway analysis, skeletal staining\",\n      \"pmids\": [\"25913037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Why neural crest cells are selectively sensitive to Pol I haploinsufficiency remains unclear\",\n        \"Contribution of individual ribosomal RNA species versus global ribosome shortage not dissected\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"An allelic series of POLR1A variants was linked to a broad phenotypic spectrum (craniofacial, cardiac, neurodevelopmental) and conditional mouse knockouts demonstrated cell-autonomous apoptosis in neural crest, second heart field, and forebrain lineages, expanding the disease paradigm beyond craniofacial dysostosis. Separately, biallelic variants were shown to cause leukodystrophy via aberrant rRNA processing and ER stress.\",\n      \"evidence\": \"Human cohort sequencing, CRISPR knock-in and Cre-lox conditional mice, patient fibroblast rRNA processing and ER stress assays\",\n      \"pmids\": [\"37075751\", \"36917474\", \"28051070\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How specific missense variants differentially affect Pol I catalytic activity versus assembly remains unclear\",\n        \"Whether ER stress in leukodystrophy is a direct consequence of unfolded protein accumulation from reduced ribosome output not proven\",\n        \"No rescue experiments with wild-type POLR1A in mouse or patient cells reported\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A nucleolar–mitochondrial signaling axis was uncovered in which POLR1A controls TFAM expression through ATF4, restraining mitophagy-dependent labile iron release and conferring ferroptosis resistance — revealing a non-canonical function linking Pol I activity to mitochondrial quality control.\",\n      \"evidence\": \"POLR1A knockdown/CX-5461 inhibition, TFAM expression analysis, mitophagy and labile iron assays, lipid peroxidation readouts, in vivo xenograft synergy with GPX4 inhibition\",\n      \"pmids\": [\"40669210\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab finding; independent replication needed\",\n        \"Whether ATF4 induction is a direct transcriptional consequence of reduced rRNA or a secondary stress response is unresolved\",\n        \"Relevance of this axis to POLR1A-associated human diseases not tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structural basis for variant-specific catalytic defects, the tissue-selective vulnerability mechanisms in ribosomopathy phenotypes, and whether the POLR1A–ATF4–TFAM ferroptosis axis operates in vivo under physiological Pol I stress.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of human Pol I with disease-associated POLR1A variants\",\n        \"Tissue-specific ribosome biogenesis thresholds not quantified\",\n        \"In vivo significance of ferroptosis regulation by POLR1A unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1, 2, 8]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [5, 6, 7, 10, 12]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 3, 7, 8]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [2, 9, 12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 10, 11, 12]}\n    ],\n    \"complexes\": [\n      \"RNA Polymerase I\"\n    ],\n    \"partners\": [\n      \"RRN3\",\n      \"SIRT7\",\n      \"PAF53\",\n      \"UBF\",\n      \"TAFI110\",\n      \"TAFI63\",\n      \"ATF4\",\n      \"TFAM\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}